ALEC stock forecast
Our latest prediction for Alector, Inc.'s stock price was made on the April 16, 2020 when the stock price was at 22.49$.
In the short term (2weeks), ALEC's stock price should underperform the market by -2.56%. During that period the price should oscillate between -12.06% and +10.43%.
In the medium term (3months), ALEC's stock price should underperform the market by -0.34%. During that period the price should oscillate between -30.42% and +29.85%.Get email alerts
Create a solid portfolio with ALEC
About Alector, Inc.
Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
At the moment the company generates 23M USD in revenues.
On its last earning announcement, the company reported a loss of -1.82$ per share.
The book value per share is 3.86$
Three months stock forecastApril 16, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|